Immediate Impact

60 standout
Sub-graph 1 of 23

Citing Papers

Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis
2024 Standout
Ulcerative Colitis in Adults
2023 Standout
1 intermediate paper

Works of Loretto Lacey being referenced

Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Changes Observed
2015
Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility
2007

Author Peers

Author Last Decade Papers Cites
Loretto Lacey 258 424 102 276 37 772
Susanne Steinmann 130 204 95 308 20 714
Christopher J. Poulos 111 308 135 349 72 954
T. J. E. M. Bakker 83 341 121 513 42 907
R.T.C.M. Koopmans 105 558 170 381 48 914
Britt‐Marie Sjölund 61 322 111 396 26 832
Jennifer Martindale‐Adams 92 436 72 532 35 943
Halima Amjad 116 427 125 557 36 988
Perry Edelman 89 315 42 367 27 855
Cadja Bachmann 102 415 57 449 22 921
Nicole R. Fowler 119 319 97 219 75 676

All Works

Loading papers...

Rankless by CCL
2026